Roche is betting the same tools that made it the world's largest producer of cancer drugs will help it tackle the growing public health crisis of antibiotic resistance as regulators and politicians encourage fresh research.
Roche returns to antibiotic research as superbug threat grows
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.